Skip to content

Pfizer Inc

Follow

13F filer, CIK 78003, New York, NY

Pfizer Inc reported $164,248,920 across 17 holdings for the quarter ended 2026-09-30, in a 13F-HR filed 2026-11-12. Its ten largest share positions make up 95.1% of the portfolio.

Accepted , ingested 13F-HR 0000078003-26-000135

Period
2026-09-30
Reported value
$164M
Holdings
17
Top 10 weight
95.1%
New
2
Sold out
2

Part of the filer group Pfizer Inc

  • PFIZER INC. (13-5315170)
  • PFIZER VENTURES (US) LLC (82-5524518)
How groups are built

Stakes and trades reported after 2026-09-30

13D, 13G and Form 4 filings by this filer's group, dated after the 13F period, on securities the quarter does not hold as shares.

  • TRXB TREX BIO INC: 13G 1,965,066 shares, 7.2% of the class, 13G filed 2026-10-16, 0000078003-26-000118Timeline
    Accepted , ingested

Largest buys vs the previous quarter

SecurityShares changeApprox. value
AGMBadded+2,076,213$21.8M
WVEnew+1,875,000$7.09M
SENSnew+2,171$21.7K
NXTCadded+10$50

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Largest sells vs the previous quarter

SecurityShares changeApprox. value
WVEexited-1,875,000-$10.9M
SENSEONICS HOLDINGS INCexited-2,171-$12.4K

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Holdings, Q3 2026

Share positions as resolved from 13F-HR 0000078003-26-000135, largest first. % of portfolio is the value over $164,248,920, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
ALLOALLOGENE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 22,032,040 shares; 2025Q1: 22,032,040 shares; 2025Q2: 22,032,040 shares; 2025Q3: 22,032,040 shares; 2025Q4: 22,032,040 shares; 2026Q1: 22,032,040 shares; 2026Q2: 22,032,040 shares; 2026Q3: 22,032,040 shares 22,032,040$36.4M22.13%0Timeline
ARVNARVINAS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 3,457,815 shares; 2025Q1: 3,457,815 shares; 2025Q2: 3,457,815 shares; 2025Q3: 3,457,815 shares; 2025Q4: 3,457,815 shares; 2026Q1: 3,457,815 shares; 2026Q2: 3,457,815 shares; 2026Q3: 3,457,815 shares 3,457,815$26.2M15.98%0Timeline
CELCCELCUITY INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 349,406 shares; 2025Q1: 349,406 shares; 2025Q2: 349,406 shares; 2025Q3: 349,406 shares; 2025Q4: 349,406 shares; 2026Q1: 295,652 shares; 2026Q2: 295,652 shares; 2026Q3: 295,652 shares 295,652$23.5M14.31%0Timeline
AGMBAGOMAB THERAPEUTICS NVQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 75,000 shares; 2026Q2: 75,000 shares; 2026Q3: 2,151,213 shares 2,151,213$22.6M13.77%+2,076,213Timeline
PYXSPYXIS ONCOLOGY INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 7,032,770 shares; 2025Q1: 7,032,770 shares; 2025Q2: 7,032,770 shares; 2025Q3: 7,032,770 shares; 2025Q4: 7,032,770 shares; 2026Q1: 7,032,770 shares; 2026Q2: 7,032,770 shares; 2026Q3: 7,032,770 shares 7,032,770$20.1M12.25%0Timeline
WVEWAVE LIFE SCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 1,875,000 shares 1,875,000$7.09M4.32%newTimeline
BHVNBIOHAVEN LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 505,645 shares; 2025Q1: 505,645 shares; 2025Q2: 505,645 shares; 2025Q3: 505,645 shares; 2025Q4: 505,645 shares; 2026Q1: 505,645 shares; 2026Q2: 505,645 shares; 2026Q3: 505,645 shares 505,645$6.57M4%0Timeline
CRBUCARIBOU BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 4,690,431 shares; 2025Q1: 4,690,431 shares; 2025Q2: 4,690,431 shares; 2025Q3: 4,690,431 shares; 2025Q4: 4,690,431 shares; 2026Q1: 4,690,431 shares; 2026Q2: 4,690,431 shares; 2026Q3: 4,690,431 shares 4,690,431$5.82M3.54%0Timeline
ORICORIC PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 5,376,344 shares; 2025Q1: 5,376,344 shares; 2025Q2: 5,376,344 shares; 2025Q3: 5,376,344 shares; 2025Q4: 5,376,344 shares; 2026Q1: 4,780,401 shares; 2026Q2: 372,904 shares; 2026Q3: 372,904 shares 372,904$4.91M2.99%0Timeline
CRDFCARDIFF ONCOLOGY INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 2,411,575 shares; 2025Q1: 2,411,575 shares; 2025Q2: 2,411,575 shares; 2025Q3: 2,411,575 shares; 2025Q4: 2,411,575 shares; 2026Q1: 2,411,575 shares; 2026Q2: 2,411,575 shares; 2026Q3: 2,411,575 shares 2,411,575$2.99M1.82%0Timeline
SPROSPERO THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 2,362,348 shares; 2025Q1: 2,362,348 shares; 2025Q2: 2,362,348 shares; 2025Q3: 2,362,348 shares; 2025Q4: 2,362,348 shares; 2026Q1: 2,362,348 shares; 2026Q2: 2,362,348 shares; 2026Q3: 2,362,348 shares 2,362,348$2.91M1.77%0Timeline
ZNTLZENTALIS PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 953,834 shares; 2025Q1: 953,834 shares; 2025Q2: 953,834 shares; 2025Q3: 953,834 shares; 2025Q4: 953,834 shares; 2026Q1: 953,834 shares; 2026Q2: 953,834 shares; 2026Q3: 953,834 shares 953,834$2.58M1.57%0Timeline
ZURAZURA BIO LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 2,970,022 shares; 2025Q1: 2,970,022 shares; 2025Q2: 2,970,022 shares; 2025Q3: 2,970,022 shares; 2025Q4: 2,970,022 shares; 2026Q1: 2,838,913 shares; 2026Q2: 538,841 shares; 2026Q3: 538,841 shares 538,841$2.18M1.33%0Timeline
NXTCNEXTCURE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 157,646 shares; 2025Q4: 157,646 shares; 2026Q1: 153,354 shares; 2026Q2: 44,347 shares; 2026Q3: 44,357 shares 44,357$225K0.14%+10Timeline
BOLTBOLT BIOTHERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 31,305 shares; 2025Q3: 31,305 shares; 2025Q4: 31,305 shares; 2026Q1: 31,305 shares; 2026Q2: 31,305 shares; 2026Q3: 31,305 shares 31,305$112K0.07%0Timeline
DNAGINKGO BIOWORKS HOLDINGS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 2,928 shares; 2025Q1: 2,928 shares; 2025Q2: 2,928 shares; 2025Q3: 2,928 shares; 2025Q4: 2,928 shares; 2026Q1: 2,928 shares; 2026Q2: 2,928 shares; 2026Q3: 2,928 shares 2,928$31.2K0.02%0Timeline
SENSSENSEONICS HLDGS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 2,171 shares 2,171$21.7K0.01%newTimeline

Sold out in Q3 2026

Positions in the previous quarter's report that this quarter's report no longer lists.

SecurityShares beforeValue beforeType
WVEWAVE LIFE SCIENCES LTD1,875,000$10.9Mshares
SENSEONICS HOLDINGS INCSENSEONICS HOLDINGS INC2,171$12.4Kshares

How Q3 2026 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0000078003-26-000135 base2026-11-12

Filings

Every filing of this filer: 13F reports and notices, the 13D and 13G it filed or is a reporting person of, and Forms 3, 4 and 5 it reported as an owner.

FilingSubjectFiledAcceptedIngested
13F-HR 0000078003-26-000135 Quarter ended 2026-09-302026-11-12
13G 0000078003-26-000118 TRXB2026-10-16
13F-HR 0000078003-26-000102 Quarter ended 2026-06-302026-08-13acceptance time not in the bulk data set
13F-HR 0000078003-26-000064 Quarter ended 2026-03-312026-05-12acceptance time not in the bulk data set
13F-HR 0000078003-26-000013 Quarter ended 2025-12-312026-02-12acceptance time not in the bulk data set
13F-HR 0000078003-25-000161 Quarter ended 2025-09-302025-11-13acceptance time not in the bulk data set
13F-HR 0000078003-25-000142 Quarter ended 2025-06-302025-08-11acceptance time not in the bulk data set
13F-HR 0000078003-25-000118 Quarter ended 2025-03-312025-05-13acceptance time not in the bulk data set
13F-HR 0000078003-25-000048 Quarter ended 2024-12-312025-02-14acceptance time not in the bulk data set